Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion-Reference-Cited by-同舟云学术

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion

Published:2024-04 Issue:2 Volume:22 Page:467-475
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Soares Andrey^ORCID,Bourlon Maria T.,Wong Alvin,Joshi Amit^ORCID,Jardim Denis,Korbenfeld Ernesto,Karak Fadi El,Orlandi Francisco,Sze Henry,Ansari Jawaher^ORCID,Zarba Jose,Mansour Mubarak Al,Manneh Ray^ORCID,Thirumulai Raja,Tsai Yu-Chieh^ORCID,Morsi Waleed Al,Powles Thomas

Funder

Pfizer

Publisher

Elsevier BV

Reference56 articles.

1. Epidemiology, aetiology and screening of bladder cancer;Cumberbatch;Transl Androl Urol,2019

2. Epidemiology of bladder cancer;Saginala;Med Sci (Basel),2020

3. Bladder cancer;Sanli;Nat Rev Dis Primers,2017

4. Role of immunotherapy in bladder cancer;Rhea;Cancer Treat Res Commun,2021

5. Management of metastatic bladder cancer;Nadal;Cancer Treat Rev,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

2. Real‐world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey;International Journal of Urology;2024-05-24

3. Implementación de los nuevos tratamientos para el tumor vesical no músculo invasivo que no responde al tratamiento con BCG. Aspectos a considerar en Latinoamérica;Actas Urológicas Españolas;2024-05

4. Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America;Actas Urológicas Españolas (English Edition);2024-05